MetLife Investment Management’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-60,169
Closed -$94.5K 2860
2025
Q2
$94.5K Buy
60,169
+25,698
+75% +$47.9K ﹤0.01% 2571
2025
Q1
$91K Sell
34,471
-25,774
-43% -$103K ﹤0.01% 2568
2024
Q4
$255K Buy
60,245
+6,517
+12% +$25.1K ﹤0.01% 2170
2024
Q3
$178K Sell
53,728
-7,278
-12% -$24.7K ﹤0.01% 2343
2024
Q2
$189K Buy
61,006
+18,719
+44% +$61.6K ﹤0.01% 2281
2024
Q1
$171K Sell
42,287
-1,989
-4% -$7.5K ﹤0.01% 2280
2023
Q4
$248K Hold
44,276
﹤0.01% 2116
2023
Q3
$236K Hold
44,276
﹤0.01% 2109
2023
Q2
$415K Hold
44,276
﹤0.01% 1824
2023
Q1
$383K Hold
44,276
﹤0.01% 1809
2022
Q4
$313K Hold
44,276
﹤0.01% 1953
2022
Q3
$439K Hold
44,276
﹤0.01% 1735
2022
Q2
$316K Buy
+44,276
New +$323K ﹤0.01% 1988

Other funds holding DCGO

MetLife Investment Management's DCGO Position: Q3 2025 in Review

MetLife Investment Management sold out of DocGo (DCGO) in Q3 2025, closing a stake of 60,169 shares — an estimated $94.5K sold.

MetLife Investment Management first reported a position in DCGO in Q2 2022 and held it in 13 quarters. The position peaked at $439K in Q3 2022. 118 funds tracked by Wall St. Rank hold DCGO as of Q3 2025.

  • MetLife Investment Management reported no remaining DocGo position as of Q3 2025 after selling out during the quarter.
  • MetLife Investment Management sold 60,169 DocGo shares in Q3 2025, an estimated $94.5K.
  • MetLife Investment Management first reported a position in DocGo in Q2 2022 and held it in 13 quarters.
  • MetLife Investment Management's DocGo position peaked at $439K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held DocGo as of Q3 2025.

Based on MetLife Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.